CASTEL SAN PIETRO, 13 July 2020 – Medacta today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for its NextARTM Augmented Reality based surgical platform for total knee arthroplasty (TKA) procedures. The NextARTM TKA is the first application of a new platform technology, which will be extended to hip, shoulder and spine procedures, …